Sponsor:
Retina Associates, Kansas City
Code:
NCT00516464
Conditions
Proliferative Diabetic Retinopathy
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Not accepted
Interventions
Lucentis (ranibizumab)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-19. This information was provided to ClinicalTrials.gov by Retina Associates, Kansas City on 2007-08-15.